Previous study had shown that PRCP, through its involvement in the pro-opiomelanocortin (POMC) system, makes it a highly promising target in the treatment of obesity and related diseases (34, 53). The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.